首页>
外文期刊>Disease Prevention Daily.
>Findings on Headache Reported by Investigators at Mazandaran University of Medical Sciences (The Efficacy of Magnesium Oxide and Sodium Valproate In Prevention of Migraine Headache: a Randomized, Controlled, Double-blind, Crossover Study)
【24h】
Findings on Headache Reported by Investigators at Mazandaran University of Medical Sciences (The Efficacy of Magnesium Oxide and Sodium Valproate In Prevention of Migraine Headache: a Randomized, Controlled, Double-blind, Crossover Study)
2021 MAY 03 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Current study results on Nervous System Diseases and Conditions - Headache have been published. According to news originating from Sari, Iran, by NewsRx correspondents, research stated, "Migraine is a disabling disorder that affects the quality of life of patients. Different medications have been used in prevention of migraine headache." Financial support for this research came from Mazandaran University of Medical Sciences. Our news journalists obtained a quote from the research from the Mazandaran University of Medical Sciences, "In this study, we evaluated the effectiveness of magnesium oxide in comparison with valproate sodium in preventing migraine headache attacks. This is a single-center, randomized, controlled, crossover trial which is double-blind, 24-week, 2-sequence, 2-period, 2-treatment. After patient randomization into two sequences, the intervention group received magnesium oxide 500 mg and the control group received valproate sodium 400 mg two tablets each day (every 12 h) for 8 weeks.
展开▼
